| Literature DB >> 16051842 |
Susan Blakeney1, Jacek Kowalski, Donna Tummolo, Joanne DeStefano, David Cooper, Min Guo, Seema Gangolli, Deborah Long, Timothy Zamb, Robert J Natuk, Robert J Visalli.
Abstract
A herpes simplex virus type 2 (HSV-2) UL24 beta-glucuronidase (UL24-betagluc) insertion mutant was derived from HSV-2 strain 186 via standard marker transfer techniques. Cell monolayers infected with UL24-betagluc yielded cytopathic effect with syncytium formation. UL24-betagluc replicated to wild-type viral titers in three different cell lines. UL24-betagluc was not virulent after intravaginal inoculation of BALB/c mice in that all inoculated animals survived doses up to 400 times the 50% lethal dose (LD50) of the parental virus. Furthermore, few UL24-betagluc-inoculated mice developed any vaginal lesions. Intravaginal inoculation of guinea pigs with UL24-betagluc at a dose equivalent to the LD50 of parental virus (approximately 5 x 10(3) PFU) was not lethal (10/10 animals survived). Although genital lesions developed in some UL24-betagluc-inoculated guinea pigs, both the overall number of lesions and the severity of disease were far less than that observed for animals infected with parental strain 186.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16051842 PMCID: PMC1182662 DOI: 10.1128/JVI.79.16.10498-10506.2005
Source DB: PubMed Journal: J Virol ISSN: 0022-538X Impact factor: 5.103